How to and should we target EBV in MS?

Svetlana Eckert,Dejan Jakimovski,Robert Zivadinov,Mark Hicar,Bianca Weinstock-Guttman
DOI: https://doi.org/10.1080/1744666x.2024.2328739
2024-03-17
Expert Review of Clinical Immunology
Abstract:Introduction The etiology of multiple sclerosis (MS) remains unknown. Pathogenesis likely relies on a complex interaction between multiple environmental, genetic, and behavioral risk factors. However, a growing body of literature supports the role of a preceding Epstein-Barr virus (EBV) infection in the majority of cases.
immunology
What problem does this paper attempt to address?